Aberdeen Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $5.81M | Buy |
|
|||||
|
2017
Q1 | $5.7M | Buy |
|
|||||
|
2016
Q4 | $4.78M | Sell |
|
|||||
|
2016
Q3 | $6.28M | Sell |
|
|||||
|
2016
Q2 | $6.01M | Sell |
|
|||||
|
2016
Q1 | $7.26M | Sell |
|
|||||
|
2015
Q4 | $10.3M | Buy |
|
|||||
|
2015
Q3 | $8.21M | Buy |
|
|||||
|
2015
Q2 | $9.3M | Sell |
|
|||||
|
2015
Q1 | $9.09M | Sell |
|
|||||
|
2014
Q4 | $12M | Sell |
|
|||||
|
2014
Q3 | $24.1M | Buy |
|
|||||
|
2014
Q2 | $11.4M | Buy |
|
|||||
|
2014
Q1 | $3.24M | Hold |
|
|||||
|
2013
Q4 | $2.81M | Hold |
|
|||||
|
2013
Q3 | $2.47M | Sell |
|
|||||
|
2013
Q2 | $1.99M | Buy |
|